Chronic myeloid leukemia in the imatinib era

Keywords

Imatinib, Myeloid leukemia, Medicine, Imatinib mesylate, Chronic myeloid leukaemia

References

• Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro.Susan M. Graham, Heather G. Jørgensen, Elaine Allan — 2002
• Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.Hagop Kantarjian, Charles L. Sawyers, Andreas Hochhaus — 2002
• Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia.Andreas Burchert, Stefan Wölfl, Manuel Schmidt — 2003
• Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.Brian Druker, Moshe Talpaz, Debra Resta — 2001
• PEGIntron and STI571 combination evaluation study (PISCES) in chronic phase chronic myeloid leukaemiaSG O'Brien, SE Vallance, Charles Craddock — 2001

Cited by

• Cost‐Efficacy of Imatinib versus Allogeneic Bone Marrow Transplantation with a Matched Unrelated Donor in the Treatment of Chronic Myelogenous Leukemia: A Decision‐Analytic ApproachGrant H. Skrepnek, Erin E. Ballard — 2005
• Imatinib (STI571) Inhibits DNA Repair in Human Leukemia Oncogenic Tyrosine Kinase-Expressing CellsIreneusz Majsterek, Michał Arabski, Agnieszka Czechowska — 2006

Related papers

• 9233 POSTER Pharmacokinetic Intra-individual Variability of Imatinib -Consequences for Therapeutic Drug Monitoring in Chronic Myeloid LeukaemiaChristophe Bardin, Xavier Declèves, Anne Vekhoff — 2011
• CCN3 enhances imatinib induced growth inhibition in chronic myeloid leukaemiaLynn McCallum, Wanhua Lu, Susan Price — 2010
• Down regulation of PDGFRα gene is associated with imatinib induced thrombocytopenia in chronic myeloid leukaemiaSameer Ahmad Guru, Musadiq A. Bhat, Mariyam Zuberi — 2017
• Utility of the trough plasma imatinib level monitoring at two time points in patients with the chronic myeloid leukemia-chronic phase.Tulika Seth, SanjeevKumar Sharma, Suman Kumar — 2014
• Expression and significance of Axl in chronic myeloid leukemia treated with imatinibMing-yin Qiao, Zhongxing Jiang — 2013
• Monitoring imatinib plasma concentrations in chronic myeloid leukemiaDarlize Hübner Martins, Sandrine Comparsi Wagner, Tamyris Vianna dos Santos — 2011
• Quantitative approaches to analyzing imatinib-treated chronic myeloid leukemia.Franziska Michor — 2007